214 related items for PubMed ID: 10343626
21. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects.
Möllmann H, Wagner M, Krishnaswami S, Dimova H, Tang Y, Falcoz C, Daley-Yates PT, Krieg M, Stöckmann R, Barth J, Lawlor C, Möllmann AC, Derendorf H, Hochhaus G.
J Clin Pharmacol; 2001 Dec; 41(12):1329-38. PubMed ID: 11762560
[Abstract] [Full Text] [Related]
22. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma.
Sorkness CA, LaForce C, Storms W, Lincourt WR, Edwards L, Rogenes PR.
Clin Ther; 1999 Feb; 21(2):353-67. PubMed ID: 10211538
[Abstract] [Full Text] [Related]
23. A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler.
Grahnén A, Jansson B, Brundin RM, Ling-Andersson A, Lönnebo A, Johansson M, Eckernäs SA.
Eur J Clin Pharmacol; 1997 Feb; 52(4):261-7. PubMed ID: 9248762
[Abstract] [Full Text] [Related]
24. Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate.
Daley-Yates PT, Deans A, Mehta R, Sousa AR.
Pulm Pharmacol Ther; 2022 Dec; 77():102171. PubMed ID: 36243386
[Abstract] [Full Text] [Related]
25. Short-term dose-response relationships for the relative systemic effects of oral prednisolone and inhaled fluticasone in asthmatic adults.
Wilson AM, Lipworth BJ.
Br J Clin Pharmacol; 1999 Oct; 48(4):579-85. PubMed ID: 10583029
[Abstract] [Full Text] [Related]
26. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients.
Casale TB, Nelson HS, Stricker WE, Raff H, Newman KB.
Ann Allergy Asthma Immunol; 2001 Nov; 87(5):379-85. PubMed ID: 11730179
[Abstract] [Full Text] [Related]
27. Relative lung delivery of fluticasone propionate via large volume spacer or nebuliser in healthy volunteers.
Dempsey OJ, Humphreys M, Coutie WJ, Lipworth BJ.
Eur J Clin Pharmacol; 2001 Nov; 57(9):637-41. PubMed ID: 11791892
[Abstract] [Full Text] [Related]
28. The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast.
Lanz MJ, Eisenlohr C, Llabre MM, Toledo Y, Lanz MA.
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):283-8. PubMed ID: 11686419
[Abstract] [Full Text] [Related]
29. Nocturnal cortisol secretion in asthmatic patients after inhalation of fluticasone propionate.
Weiner P, Berar-Yanay N, Davidovich A, Magadle R.
Chest; 1999 Oct; 116(4):931-4. PubMed ID: 10531155
[Abstract] [Full Text] [Related]
30. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
Kerwin EM, Nathan RA, Meltzer EO, Ortega HG, Yancey SW, Schoaf L, Dorinsky PM.
Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
[Abstract] [Full Text] [Related]
31. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
Harrison TW, Wisniewski A, Honour J, Tattersfield AE.
Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010
[Abstract] [Full Text] [Related]
32. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[Abstract] [Full Text] [Related]
33. Fluticasone propionate in children with moderate asthma.
Hoekstra MO, Grol MH, Bouman K, Stijnen T, Köeter GH, Kauffman HF, Gerritsen J.
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1039-44. PubMed ID: 8887604
[Abstract] [Full Text] [Related]
34. Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function.
Nielsen LP, Dahl R.
Am J Respir Crit Care Med; 2000 Dec; 162(6):2053-7. PubMed ID: 11112113
[Abstract] [Full Text] [Related]
35. Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma.
Woodcock A, Bleecker ER, Busse WW, Lötvall J, Snowise NG, Frith L, Jacques L, Haumann B, Bateman ED.
Respir Res; 2011 Dec 21; 12(1):160. PubMed ID: 22188590
[Abstract] [Full Text] [Related]
36. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.
van Noord JA, Schreurs AJ, Mol SJ, Mulder PG.
Thorax; 1999 Mar 21; 54(3):207-12. PubMed ID: 10325895
[Abstract] [Full Text] [Related]
37. Comparative efficacy, safety, and effect on quality of life of triamcinolone acetonide and fluticasone propionate aqueous nasal sprays in patients with fall seasonal allergic rhinitis.
Gross G, Jacobs RL, Woodworth TH, Georges GC, Lim JC.
Ann Allergy Asthma Immunol; 2002 Jul 21; 89(1):56-62. PubMed ID: 12141721
[Abstract] [Full Text] [Related]
38. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study.
Brutsche MH, Brutsche IC, Munawar M, Langley SJ, Masterson CM, Daley-Yates PT, Brown R, Custovic A, Woodcock A.
Lancet; 2000 Aug 12; 356(9229):556-61. PubMed ID: 10950233
[Abstract] [Full Text] [Related]
39. Fluticasone propionate and budesonide do not influence bone metabolism in the long term treatment of asthma.
Harmanci E, Colak O, Metintas M, Alatas O, Yurdasiper A.
Allergol Immunopathol (Madr); 2001 Aug 12; 29(1):22-7. PubMed ID: 11449531
[Abstract] [Full Text] [Related]
40. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma.
Pearlman DS, Noonan MJ, Tashkin DP, Goldstein MF, Hamedani AG, Kellerman DJ, Schaberg A.
Ann Allergy Asthma Immunol; 1997 Apr 12; 78(4):356-62. PubMed ID: 9109702
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
